Dr Cassandra Kennedy
banner
cassandrakennedy.bsky.social
Dr Cassandra Kennedy
@cassandrakennedy.bsky.social
Chemical biologist at The Francis Crick Institute, previously Tate group PhD at Imperial
Very happy to share two back-to-back preprints of my postdoc work on bacterial NEL E3 ligases from my time in @katrinrittinger.bsky.social lab at @crick.ac.uk in collaboration with the ChemBio team at GSK (1/4)
May 21, 2025 at 2:26 PM
Reposted by Dr Cassandra Kennedy
Reposted by Dr Cassandra Kennedy
Great @chemrxiv.bsky.social preprint by a team of GSK around @jtbush.bsky.social. They showcase the power of single- and multi-step direct-to-biology approaches by developing a potent, cell-active actylamide inhibitor for WRN helicase. chemrxiv.org/engage/...
March 17, 2025 at 3:00 PM
Reposted by Dr Cassandra Kennedy
Interesting paper by the groups of @katrinrittinger.bsky.social and @jtbush.bsky.social in @commschem.bsky.social. DIA-based chemical proteomics in combination with direct-to-biology compound optimization identifies new, enantioselective inhibitors for the DUB OTUD7B. www.nature.com/articles/s42...
Enantioselective OTUD7B fragment discovery through chemoproteomics screening and high-throughput optimisation - Communications Chemistry
The ovarian tumour protease (OTU) family of deubiquitinating enzymes (DUBs) are biochemically well-characterised and of therapeutic interest, however, only a few tool compounds exist to study their ce...
www.nature.com
January 17, 2025 at 5:25 AM